Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03697148 · ClinicalTrials.gov registry record · NA

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

A NA study of Prostate Carcinoma, sponsored by ECOG-ACRIN Cancer Research Group.

Active
Registry status
NA
Development phase
852
Enrollment target
20
Study locations

NCT03697148 is a NA study of Prostate Carcinoma that is active but no longer recruiting, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 852 participants, below the 1,487-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (43% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03697148, a NA study of Prostate Carcinoma, is active but no longer recruiting, sponsored by ECOG-ACRIN Cancer Research Group.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
852 participants
Enrollment target
20
Study locations

Study Summary

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

Conditions Studied

Prostate Carcinoma

Interventions

  • DIAGNOSTIC_TEST Multiparametric Magnetic Resonance Imaging

Study Locations (20)

Hawaii

  • Queen's Medical Center - Honolulu
  • Straub Clinic and Hospital - Honolulu
  • Pali Momi Medical Center - ‘Aiea
  • Straub Pearlridge Clinic - ‘Aiea

Michigan

  • Henry Ford Hospital - Detroit
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital - Grand Rapids
  • Henry Ford West Bloomfield Hospital - West Bloomfield

Arizona

  • Mayo Clinic Hospital in Arizona - Phoenix
  • Mayo Clinic in Arizona - Scottsdale

Florida

  • University of Florida Health Science Center - Jacksonville - Jacksonville
  • Mayo Clinic in Florida - Jacksonville

Kansas

  • University of Kansas Cancer Center - Kansas City
  • University of Kansas Hospital-Indian Creek Campus - Overland Park

Louisiana

  • East Jefferson General Hospital - Metairie
  • LSU Healthcare Network / Metairie Multi-Specialty Clinic - Metairie

Connecticut

  • Yale University - New Haven

Illinois

  • Midwestern Regional Medical Center - Zion

Trial Details

FieldValue
Enrollment Target 852 participants
Start Date 2019-02-11
Est. Completion 2026-08-31
Phase NA

Sponsor

ECOG-ACRIN Cancer Research Group

75 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03697148

The ClinicalTrials.gov registry entry for NCT03697148 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 852 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,487-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (43% lower). The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Multiparametric Magnetic Resonance Imaging is the first listed.

NCT03697148 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Hawaii, Michigan, Arizona.

Frequently Asked Questions

What is clinical trial NCT03697148 about?

NCT03697148 is a clinical study titled "Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer". This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

What is the current status of trial NCT03697148?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 852 participants. The study started on 2019-02-11. Estimated completion is 2026-08-31.

What conditions does trial NCT03697148 study?

This clinical trial studies the following conditions: Prostate Carcinoma.

What interventions are being tested in trial NCT03697148?

The interventions under investigation include: Multiparametric Magnetic Resonance Imaging (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03697148?

This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03697148 being conducted?

This trial has 20 study locations across Arizona, Connecticut, Florida, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Carcinoma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.